1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2 VIETNAM PROFESSIONAL ACNE MEDICATION MARKET – EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2023 - 2030, MILLION USD
3 PORTER’S FIVE FORCE MODEL ANALYSIS
3.1 BARGAINING POWER OF SUPPLIERS
3.2 BARGAINING POWER OF BUYERS
3.3 DEGREE OF COMPETITION
3.4 THREAT OF SUBSTITUTE
3.5 THREAT OF NEW ENTRANTS
4 MARKET SHARE ANALYSIS
4.1 MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023
5 MARKET DYNAMICS
5.1 GROWTH DRIVERS
5.1.1 DRIVER 1
5.1.2 DRIVER 2
5.1.3 DRIVER 3
5.1.4 DRIVER 4
5.2 CHALLENGES
5.2.1 CHALLENGE 1
5.2.2 CHALLENGE 2
5.2.3 CHALLENGE 3
5.2.4 CHALLENGE 4
5.3 OPPORTUNITIES
5.3.1 OPPORTUNITY 1
5.3.2 OPPORTUNITY 2
6 VIETNAM PROFESSIONAL ACNE MEDICATION MARKET BY ACNE TYPE
6.1 OVERVIEW
6.2 INFLAMMATORY ACNE MARKET
6.3 NON-INFLAMMATORY ACNE MARKET
7 VIETNAM PROFESSIONAL ACNE MEDICATION MARKET BY FORMULATION
7.1 OVERVIEW
7.2 TOPICAL MEDICATIONS MARKET
7.3 ORAL MEDICATIONS MARKET
8 VIETNAM PROFESSIONAL ACNE MEDICATION MARKET BY THERAPEUTIC CLASS
8.1 OVERVIEW
8.2 RETINOIDS MARKET
8.3 ANTIBIOTICS MARKET
8.4 SALICYLIC ACID MARKET
8.5 BENZOYL PEROXIDE MARKET
8.6 OTHERS MARKET
9 VIETNAM PROFESSIONAL ACNE MEDICATION MARKET BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 MED SPA MARKET
9.3 AESTHETICIAN MARKET
9.4 DERMATOLOGIST MARKET
9.5 OTHER PROFESSIONAL CHANNELS MARKET
10 COMPANY PROFILES
10.1 ALMIRALL S.A.
10.1.1 COMPANY OVERVIEW
10.1.2 COMPANY SNAPSHOT
10.1.3 OPERATING BUSINESS SEGMENTS
10.1.4 PRODUCT PORTFOLIO
10.1.5 BUSINESS PERFORMANCE
10.1.6 BUSINESS SEGMENTS
10.1.7 GEOGRAPHIC SEGMENTS
10.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.1.9 PRIMARY MARKET COMPETITORS
10.2 BAUSCH HEALTH COMPANIES, INC.
10.2.1 COMPANY OVERVIEW
10.2.2 COMPANY SNAPSHOT
10.2.3 OPERATING BUSINESS SEGMENTS
10.2.4 PRODUCT PORTFOLIO
10.2.5 BUSINESS PERFORMANCE
10.2.6 BUSINESS SEGMENTS
10.2.7 GEOGRAPHIC SEGMENTS
10.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.2.9 PRIMARY MARKET COMPETITORS
10.3 GLAXOSMITHKLINE PLC (GSK)
10.3.1 COMPANY OVERVIEW
10.3.2 COMPANY SNAPSHOT
10.3.3 OPERATING BUSINESS SEGMENTS
10.3.4 PRODUCT PORTFOLIO
10.3.5 BUSINESS PERFORMANCE
10.3.6 BUSINESS SEGMENTS
10.3.7 GEOGRAPHIC SEGMENTS
10.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.3.9 PRIMARY MARKET COMPETITORS
10.4 GALDERMA S.A.
10.4.1 COMPANY OVERVIEW
10.4.2 COMPANY SNAPSHOT
10.4.3 OPERATING BUSINESS SEGMENTS
10.4.4 PRODUCT PORTFOLIO
10.4.5 BUSINESS PERFORMANCE
10.4.6 BUSINESS SEGMENTS
10.4.7 GEOGRAPHIC SEGMENTS
10.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.4.9 PRIMARY MARKET COMPETITORS
10.5 SUN PHARMACEUTICAL INDUSTRIES LIMITED
10.5.1 COMPANY OVERVIEW
10.5.2 COMPANY SNAPSHOT
10.5.3 OPERATING BUSINESS SEGMENTS
10.5.4 PRODUCT PORTFOLIO
10.5.5 BUSINESS PERFORMANCE
10.5.6 BUSINESS SEGMENTS
10.5.7 GEOGRAPHIC SEGMENTS
10.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.5.9 PRIMARY MARKET COMPETITORS
10.6 TEVA PHARMACEUTICAL INDUSTRIES LTD.
10.6.1 COMPANY OVERVIEW
10.6.2 COMPANY SNAPSHOT
10.6.3 OPERATING BUSINESS SEGMENTS
10.6.4 PRODUCT PORTFOLIO
10.6.5 BUSINESS PERFORMANCE
10.6.6 BUSINESS SEGMENTS
10.6.7 GEOGRAPHIC SEGMENTS
10.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.6.9 PRIMARY MARKET COMPETITORS
10.7 JOHNSON AND JOHNSON
10.7.1 COMPANY OVERVIEW
10.7.2 COMPANY SNAPSHOT
10.7.3 OPERATING BUSINESS SEGMENTS
10.7.4 PRODUCT PORTFOLIO
10.7.5 BUSINESS PERFORMANCE
10.7.6 BUSINESS SEGMENTS
10.7.7 GEOGRAPHIC SEGMENTS
10.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.7.9 PRIMARY MARKET COMPETITORS
10.8 ELI LILLY AND COMPANY
10.8.1 COMPANY OVERVIEW
10.8.2 COMPANY SNAPSHOT
10.8.3 OPERATING BUSINESS SEGMENTS
10.8.4 PRODUCT PORTFOLIO
10.8.5 BUSINESS PERFORMANCE
10.8.6 BUSINESS SEGMENTS
10.8.7 GEOGRAPHIC SEGMENTS
10.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.8.9 PRIMARY MARKET COMPETITORS
10.9 MYLAN N.V.
10.9.1 COMPANY OVERVIEW
10.9.2 COMPANY SNAPSHOT
10.9.3 OPERATING BUSINESS SEGMENTS
10.9.4 PRODUCT PORTFOLIO
10.9.5 BUSINESS PERFORMANCE
10.9.6 BUSINESS SEGMENTS
10.9.7 GEOGRAPHIC SEGMENTS
10.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.9.9 PRIMARY MARKET COMPETITORS
10.10 DAIICHI SANKYO COMPANY, LTD
10.10.1 COMPANY OVERVIEW
10.10.2 COMPANY SNAPSHOT
10.10.3 OPERATING BUSINESS SEGMENTS
10.10.4 PRODUCT PORTFOLIO
10.10.5 BUSINESS PERFORMANCE
10.10.6 BUSINESS SEGMENTS
10.10.7 GEOGRAPHIC SEGMENTS
10.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
10.10.9 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
TABLE 2. INFLAMMATORY ACNE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 3. NON-INFLAMMATORY ACNE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 4. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
TABLE 5. TOPICAL MEDICATIONS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 6. ORAL MEDICATIONS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 7. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
TABLE 8. RETINOIDS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 9. ANTIBIOTICS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 10. SALICYLIC ACID, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 11. BENZOYL PEROXIDE, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 12. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 13. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
TABLE 14. MED SPA, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 15. AESTHETICIAN, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 16. DERMATOLOGIST, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 17. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, 2023-2030, (MILLION USD)
TABLE 18. BAYER AG: COMPANY SNAPSHOT
TABLE 19. BAYER AG: OPERATING BUSINESS SEGMENTS
TABLE 20. BAYER AG: PRODUCT PORTFOLIO
TABLE 21. BAYER AG: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 22. BAYER AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 23. BAYER AG: KEY STRATERGY
TABLE 24. NESTLE S.A.: COMPANY SNAPSHOT
TABLE 25. NESTLE S.A.: OPERATING BUSINESS SEGMENTS
TABLE 26. NESTLE S.A.: PRODUCT PORTFOLIO
TABLE 27. NESTLE S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 28. NESTLE S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 29. NESTLE S.A.: KEY STRATERGY
TABLE 30. PFIZER INC.: COMPANY SNAPSHOT
TABLE 31. PFIZER INC.: OPERATING BUSINESS SEGMENTS
TABLE 32. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 33. PFIZER INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 34. PFIZER INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 35. PFIZER INC.: KEY STRATERGY
TABLE 36. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 37. JOHNSON AND JOHNSON: OPERATING BUSINESS SEGMENTS
TABLE 38. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 39. JOHNSON AND JOHNSON: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 40. JOHNSON AND JOHNSON: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 41. JOHNSON AND JOHNSON: KEY STRATERGY
TABLE 42. ROCHE HOLDING AG: COMPANY SNAPSHOT
TABLE 43. ROCHE HOLDING AG: OPERATING BUSINESS SEGMENTS
TABLE 44. ROCHE HOLDING AG: PRODUCT PORTFOLIO
TABLE 45. ROCHE HOLDING AG: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 46. ROCHE HOLDING AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 47. ROCHE HOLDING AG: KEY STRATERGY
TABLE 48. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 49. GLAXOSMITHKLINE PLC: OPERATING BUSINESS SEGMENTS
TABLE 50. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 51. GLAXOSMITHKLINE PLC: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 52. GLAXOSMITHKLINE PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 53. GLAXOSMITHKLINE PLC: KEY STRATERGY
TABLE 54. GALDERMA S.A.: COMPANY SNAPSHOT
TABLE 55. GALDERMA S.A.: OPERATING BUSINESS SEGMENTS
TABLE 56. GALDERMA S.A.: PRODUCT PORTFOLIO
TABLE 57. GALDERMA S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 58. GALDERMA S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 59. GALDERMA S.A.: KEY STRATERGY
TABLE 60. ALLERGAN PLC: COMPANY SNAPSHOT
TABLE 61. ALLERGAN PLC: OPERATING BUSINESS SEGMENTS
TABLE 62. ALLERGAN PLC: PRODUCT PORTFOLIO
TABLE 63. ALLERGAN PLC: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 64. ALLERGAN PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 65. ALLERGAN PLC: KEY STRATERGY
TABLE 66. STIEFEL LABORATORIES INC.: COMPANY SNAPSHOT
TABLE 67. STIEFEL LABORATORIES INC.: OPERATING BUSINESS SEGMENTS
TABLE 68. STIEFEL LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 69. STIEFEL LABORATORIES INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 70. STIEFEL LABORATORIES INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 71. STIEFEL LABORATORIES INC.: KEY STRATERGY
TABLE 72. BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
TABLE 73. BAUSCH HEALTH COMPANIES INC.: OPERATING BUSINESS SEGMENTS
TABLE 74. BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
TABLE 75. BAUSCH HEALTH COMPANIES INC.: SALES BY BUSINESS SEGMENTS (2021-2023)
TABLE 76. BAUSCH HEALTH COMPANIES INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)
TABLE 77. BAUSCH HEALTH COMPANIES INC.: KEY STRATERGY
LIST OF FIGURES
FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)
FIGURE 7. INFLAMMATORY ACNE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 8. NON-INFLAMMATORY ACNE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 9. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)
FIGURE 10. TOPICAL MEDICATIONS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 11. ORAL MEDICATIONS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 12. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)
FIGURE 13. RETINOIDS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 14. ANTIBIOTICS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 15. SALICYLIC ACID, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 16. BENZOYL PEROXIDE, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 17. OTHERS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 18. VIETNAM PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)
FIGURE 19. MED SPA, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 20. AESTHETICIAN, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 21. DERMATOLOGIST, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 22. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, 2023-2030, (MILLION USD)
FIGURE 23. BAYER AG: NET SALES, (2021-2023)
FIGURE 24. BAYER AG: PRIMARY MARKET COMPETITORS
FIGURE 25. NESTLE S.A.: NET SALES, (2021-2023)
FIGURE 26. NESTLE S.A.: PRIMARY MARKET COMPETITORS
FIGURE 27. PFIZER INC.: NET SALES, (2021-2023)
FIGURE 28. PFIZER INC.: PRIMARY MARKET COMPETITORS
FIGURE 29. JOHNSON AND JOHNSON: NET SALES, (2021-2023)
FIGURE 30. JOHNSON AND JOHNSON: PRIMARY MARKET COMPETITORS
FIGURE 31. ROCHE HOLDING AG: NET SALES, (2021-2023)
FIGURE 32. ROCHE HOLDING AG: PRIMARY MARKET COMPETITORS
FIGURE 33. GLAXOSMITHKLINE PLC: NET SALES, (2021-2023)
FIGURE 34. GLAXOSMITHKLINE PLC: PRIMARY MARKET COMPETITORS
FIGURE 35. GALDERMA S.A.: NET SALES, (2021-2023)
FIGURE 36. GALDERMA S.A.: PRIMARY MARKET COMPETITORS
FIGURE 37. ALLERGAN PLC: NET SALES, (2021-2023)
FIGURE 38. ALLERGAN PLC: PRIMARY MARKET COMPETITORS
FIGURE 39. STIEFEL LABORATORIES INC.: NET SALES, (2021-2023)
FIGURE 40. STIEFEL LABORATORIES INC.: PRIMARY MARKET COMPETITORS
FIGURE 41. BAUSCH HEALTH COMPANIES INC.: NET SALES, (2021-2023)
FIGURE 42. BAUSCH HEALTH COMPANIES INC.: PRIMARY MARKET COMPETITORS